Industry Partnerships, Spin-offs

Research at the Laboratory of BioChemistry is balanced between fundamental and applied science. ESPCI ParisTech strongly supports innovation. We aim to benefit from and contribute to this exceptional environment.

Industry Partnerships

We have many partnerships ongoing with industrial partners from the pharmaceutical or IVD industry, or from the bioprocess domain. Collaboration occurs through research contracts, common public-funded R&D projects, shared staff, CIFRE PhD students.

An example is the OSIRIS project in collaboration with the Soufflet Group.

Spin-offs

Prof. Andrew Griffiths co-founded RainDance Technologies Inc. with Jérôme Bibette and David Weitz in 2005, bought by BioRad in 2017 for $87 million dollars.

In 2013 and 2014 he co-founded HiFiBiO and Biomillenia with David Weitz, Jérôme Bibette, Robert Nicol and Bradley Bernstein.

In 2017 he co-founded Cyprio with Jérôme Bibette.

In 2020, he co-founded Minos Biosciences with Patrick Tabeling, Aurélien de Reyniès, Jérome Cros, Yannick Rondelez, Hubert Geisler and Gaël Blivet.
Spin-off from ESPCI, Minos Biosciences is developing a unique spatially-resolved, multi-modal, single-cell analysis system for fundamental, applied and clinical research and diagnostic. The Minos system combines state-of-the-art microfluidics, molecular biology, image analysis and bioinformatics.
Job offers are available on: Minos on Linkedin